With this feature, VuComp has added the tomosynthesis slice information into the SR so that workstations will have the ability to display the CAD marks directly on the tomosynthesis slices. Additionally, tomosynthesis findings will be shown as enhanced marks on the 2-D images.
VuComp is working closely with the workstation vendors to continue to enhance the integration process.
This feature will be made available as part of VuComp's M-Vu CAD System for breast tomosynthesis. The M-Vu CAD system for breast tomosynthesis is currently under review by the U.S. Food and Drug Administration (FDA), pending approval.
For more information: www.vucomp.com